Detection of Gastric Cancer with Novel Methylated DNA Markers: Discovery, Tissue Validation, and Pilot Testing in Plasma

OBJECTIVE: Gastric adenocarcinoma (GAC) is the third most common cause of cancer mortality worldwide. Accurate and affordable non-invasive detection methods have potential value for screening and surveillance. Herein, we identify novel methylated DNA markers (MDMs) for GAC, validate their discrimina...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Cancer Res
Autores principales: Anderson, Bradley W., Suh, Yun-Suhk, Choi, Boram, Lee, Hyuk-Joon, Yab, Tracy C., Taylor, William R., Dukek, Brian A., Berger, Calise K., Cao, Xiaoming, Foote, Patrick H., Devens, Mary E., Boardman, Lisa A., Kisiel, John B., Mahoney, Douglas W., Slettedahl, Seth W., Allawi, Hatim T., Lidgard, Graham P., Smyrk, Thomas C., Yang, Han-Kwang, Ahlquist, David A.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2018
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6239895/
https://ncbi.nlm.nih.gov/pubmed/29844130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-17-3364
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares